Search

everythinglearnresearchcommunity

for

Search:↓

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

Injecting CD34+ cell-containing platelet-rich plasma can improve pattern hair loss more than placental extract treatment.

Injecting CD34+ cell-containing platelet-rich plasma into the scalp can improve hair count and thickness in people with pattern hair loss.

Mesotherapy medications may help promote hair growth.

Different levels of shear stress affect where cells move and gather in a 3D-printed model, helping to better understand cell behavior in blood vessels.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

A 10-year-old boy with abnormal genital development had surgery and tests to find the cause and plan treatment.

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

Copper treatments increase copper in all tissues, but brindled female mice accumulate much more copper in their kidneys without clinical effects, unlike brindled male mice where brain copper deficiency is clinically significant.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Spironolactone treatment increases the amount of testosterone available in the body.

A substance called DKK-1 increases in balding areas and causes hair cells to die when exposed to DHT.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Platelet-rich plasma may help with hair growth and skin quality but more research is needed to confirm its effectiveness.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The article concludes that better understanding gene regulation related to seasonal changes can offer insights into the mechanisms of seasonal timing in mammals.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

Platelet-rich plasma may have some benefits in dermatology, but there's not enough evidence to widely recommend its use.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Neurosteroids show promise for treating epilepsy and more research is needed.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.